Transasia Bio-Medicals Executive and Leadership Team

September, 2026

Leadership Overview

Transasia Bio-Medicals has 5 executives leading key functions including strategic direction, global market expansion, financial management, corporate affairs, and operational excellence.

Committed to advancing global healthcare standards, Transasia Bio-Medicals delivers high-precision diagnostic solutions to clinical laboratories and research facilities through continuous innovation and reliable in-vitro diagnostic technology.

Leadership Roles at Transasia Bio-Medicals

  • Chief Executive Officer - Angie Bartlett
  • Global Chief Executive Officer - Nishant Saxena
  • Chief Financial Officer - Aditi Pai
  • Senior President, Corporate Affairs - Anil Jotwani
  • President, Operations - Anitya Doorwar
  • Angie Bartlett - Chief Executive Officer

    Angie Bartlett, the Chief Executive Officer at Transasia Bio-Medicals, directs the overarching strategic vision for the organization. Focusing on the domestic market, the Chief Executive Officer architects growth initiatives that align with the company's mission to provide high-quality in-vitro diagnostics. This leadership role involves constant collaboration with the board to ensure the H 7100 Advanced Hematology Analyzer and other core product lines maintain market dominance. By optimizing internal resource allocation, Angie Bartlett drives efficiency across all clinical chemistry and immunology departments. The Chief Executive Officer monitors competitive landscapes to identify emerging opportunities in the Indian healthcare sector. Through rigorous oversight of product development cycles, the Chief Executive Officer ensures that every diagnostic instrument meets the highest standards of accuracy. Ultimately, Bartlett secures the long-term viability of the company by fostering a culture of technical excellence and customer-centric innovation within the domestic diagnostic landscape.

    Nishant Saxena - Global Chief Executive Officer

    Nishant Saxena, the Global Chief Executive Officer at Transasia Bio-Medicals, manages the international expansion of the company's diagnostic portfolio. Overseeing operations across diverse global markets, the Global Chief Executive Officer ensures that Erba Mannheim products reach clinical laboratories and research institutions worldwide. This leadership role requires navigating complex regulatory environments to facilitate the distribution of automated ELISA processors and critical care reagents. By establishing strategic partnerships with international healthcare providers, Nishant Saxena drives the global adoption of advanced diagnostic solutions. The Global Chief Executive Officer coordinates with regional teams to adapt product offerings to specific market needs, ensuring consistent performance and reliability. Through the implementation of scalable business models, the Global Chief Executive Officer enhances the company's footprint in emerging and established markets alike. Ultimately, Saxena strengthens the global brand presence by delivering consistent value to international diagnostic partners and healthcare stakeholders.

    Aditi Pai - Chief Financial Officer

    Aditi Pai, the Chief Financial Officer at Transasia Bio-Medicals, manages the fiscal health and capital allocation strategies of the organization. Overseeing the financial planning and analysis departments, the Chief Financial Officer ensures that investments in R&D for hematology and molecular diagnostics remain sustainable. This leadership role involves maintaining rigorous financial controls to support the company's expansive product range, including hemostasis and urinalysis instruments. By optimizing the balance sheet, Aditi Pai drives the funding necessary for technological advancements and infrastructure upgrades. The Chief Financial Officer collaborates with executive leadership to assess the financial viability of new market entries and product launches. Through precise risk management and transparent reporting, the Chief Financial Officer maintains investor confidence and supports long-term growth objectives. Ultimately, Pai secures the financial foundation required for the company to continue providing reliable diagnostic solutions to healthcare providers and research institutions across the globe.

    Anil Jotwani - Senior President, Corporate Affairs

    Anil Jotwani, the Senior President, Corporate Affairs at Transasia Bio-Medicals, manages external relations and regulatory compliance across the company's diverse diagnostic sectors. Overseeing interactions with government bodies and industry associations, the Senior President, Corporate Affairs ensures that the company adheres to all standards for blood banking and critical care diagnostics. This leadership role involves shaping public policy engagement to support the adoption of innovative in-vitro diagnostic solutions. By fostering strong relationships with key stakeholders, Anil Jotwani drives the company's reputation as a leader in clinical chemistry and diabetes management. The Senior President, Corporate Affairs coordinates with legal and compliance teams to mitigate risks associated with international trade and product certification. Through proactive communication strategies, the Senior President, Corporate Affairs aligns corporate activities with broader healthcare goals. Ultimately, Jotwani protects the company's interests while promoting the vital role of diagnostics in improving patient outcomes.

    Anitya Doorwar - President, Operations

    Anitya Doorwar, the President, Operations at Transasia Bio-Medicals, directs the manufacturing and supply chain logistics for the entire diagnostic product range. Overseeing the production of instruments and reagents, the President, Operations ensures that facilities maintain high output quality for hematology, hemostasis, and immunology lines. This leadership role involves streamlining the assembly of complex diagnostic equipment like the H 7100 Advanced Hematology Analyzer to meet global demand. By implementing lean manufacturing principles, Anitya Doorwar drives operational efficiency and reduces lead times for clinical laboratories. The President, Operations collaborates with procurement teams to secure high-quality raw materials for molecular diagnostics and urinalysis products. Through the continuous monitoring of production metrics, the President, Operations maintains the integrity of the supply chain across all regional distribution hubs. Ultimately, Doorwar ensures that the company delivers reliable, high-performance diagnostic tools to healthcare providers and research facilities on time and within budget.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Transasia Bio-Medicals Top Executives and Leadership Team

    Who leads Transasia Bio-Medicals?
    Transasia Bio-Medicals is led by Angie Bartlett (Chief Executive Officer), along with executives such as Nishant Saxena (Global Chief Executive Officer) and Aditi Pai (Chief Financial Officer).
    Who is part of Transasia Bio-Medicals’s executive team?
    The executive team of Transasia Bio-Medicals includes leaders such as Angie Bartlett (Chief Executive Officer), Nishant Saxena (Global Chief Executive Officer), Aditi Pai (Chief Financial Officer) and other senior executives.
    How many executives does Transasia Bio-Medicals have?
    Transasia Bio-Medicals has 5 executives leading key business areas.
    What roles are included in Transasia Bio-Medicals’s leadership team?
    The leadership team of Transasia Bio-Medicals includes roles such as Chief Executive Officer, Global Chief Executive Officer, Chief Financial Officer, Senior President, Corporate Affairs, President, Operations.